Wiley Blackwell

SHERPA: Unknown

People

  1. Dogan
    Dogan
  2. Horwitz
    Horwitz
  3. Moskowitz
    Moskowitz
  4. Kumar
    Kumar
  5. Noy
    Noy
  6. Yahalom
    Yahalom
  7. Zelenetz
    Zelenetz
  8. Palomba
    Palomba
  9. Hamlin
    Hamlin
  10. Roshal
    Roshal

Groups

  1. Department of Pathology and Laboratory Medicine (27)
  2. Center for Hematologic Malignancies (19)
  3. Department of Medicine (19)
  4. Hematologic Malignancies, Division of (19)
  5. Lymphoma (18)
  6. Population Sciences Research Program (14)
  7. Sloan Kettering Institute Postdocs (12)
  8. Survivorship Research (9)
  9. Epidemiology and Biostatistics (8)
  10. Hematology-Oncology Fellows (8)
Search Within
  1. "Ahmet Dogan"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (12)
  3. Research Letter (1)
Groups
  1. Department of Pathology and Laboratory Medicine (27)
  2. Center for Hematologic Malignancies (19)
  3. Department of Medicine (19)
  4. Hematologic Malignancies, Division of (19)
  5. Lymphoma (18)
  6. Population Sciences Research Program (14)

More Groups

People
  1. Ahmet Dogan (27)
  2. Steven Horwitz (14)
  3. Alison Moskowitz (9)
  4. Andrew Zelenetz (7)
  5. Anita Kumar (7)
  6. Ariela Noy (7)

More People

Years
  1. 2024 (2)
  2. 2023 (6)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (1)
  6. 2019 (7)

More Years

Publications
  1. Hematological Oncology (13)
  2. Histopathology (5)
  3. Cytometry Part B—Clinical Cytometry (4)
  4. Breast Journal (2)
  5. Cancer Medicine (1)
  6. Internal Medicine Journal (1)

More Publications

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cyclin D1-negative and SOX11-positive B-cell lymphoma with CD5 and CD10 coexpression and MYC rearrangement: A diagnostic challenge
    Journal Article

    Yan, M.; Zhang, Y.; Dogan, A.; Yabe, M.
    eJHaem (2024)

    Fulltext@MSK | Save
  • Role of flow cytometric immunophenotyping in the diagnosis of breast implant-associated anaplastic large cell lymphoma: A 6-year, single-institution experience
    Journal Article

    Chan, A.; Auclair, R.; Gao, Q.; Ghione, P.; Horwitz, S.; Dogan, A.; Roshal, M.; Lin, O.
    Cytometry Part B—Clinical Cytometry (2024)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Genetic alterations in follicular lymphoma predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Lee, J.; Fregonese, B.; Hajj, C.; Cedarquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Long‐term follow-up of multicenter phase II trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in previously untreated patients with CLL/SLL
    Meeting Abstract

    Soumerai, J. D.; Dogan, A.; Seshan, V.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Abramson, J. S.; Hamilton, A. M.; Noy, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • BRCA1/2 mutations impact on the development of breast implant‐associated lymphoma (BIA‐ALCL) in women with breast cancer reconstructed with textured breast implants
    Meeting Abstract

    Ghione, P.; Arcila, M.; Joseph, V.; Dogan, A.; Cordeiro, P.; Salles, G.; de Jong, D.; Horwitz, S.; Mandelker, D.; van Leeuwen, F.
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Abnormal B-lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia
    Journal Article

    Chan, A.; Kumar, P.; Gao, Q.; Baik, J.; Sigler, A.; Londono, D.; Liu, Y.; Arcila, M. E.; Dogan, A.; Zhang, Y.; more...
    Cytometry Part B—Clinical Cytometry (2023)

    Fulltext@MSK | Save
  • PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome
    Journal Article

    Lewis, N. E.; Gao, Q.; Petrova-Drus, K.; Pulitzer, M.; Sigler, A.; Baik, J.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Cytometry Part B—Clinical Cytometry (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort
    Journal Article

    Withers, B.; McCaughan, G.; Hayward, C.; Kotlyar, E.; Jabbour, A.; Rainer, S.; De Angelis, E.; Horvath, N.; Milliken, S.; Dogan, A.; more...
    Internal Medicine Journal (2022)

    Fulltext@MSK | Save